Health ❯ Medicine ❯ Neurology

Neurodegenerative Diseases

Alzheimer's Disease Parkinson's Disease Disease-Modifying Treatment Huntington's Disease Alzheimer’s Disease Amyotrophic Lateral Sclerosis GGC Repeat Disorders Alzheimer's Treatment Dementia

Copper Compound Lowers Amyloid and Restores Blood–Brain Barrier Pumps in Alzheimer’s Mice

Authors say prior safety data for Cu(ATSM) supports moving toward early human testing.

Glucosamine Linked to Faster Dementia Progression and Higher Death Risk, Study Finds

High‑Dose Psilocybin Sessions Produced Temporary Gains in an Elderly Alzheimer’s Patient

ETH Zurich Pins GRK2 Aggregation as Alzheimer’s Target and Reveals 'Compound 10' That Slows Decline in Mice

Virtual Reality Test Predicts Short-Term Brain Shrinkage in Healthy Adults

Lowering Nell2 Reverses APOE4-Linked Brain Hyperactivity in Mice

Alzheimer’s Theory Shifts Focus to Microtubules as Amyloid Beta Crowds Out Tau

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Alzheimer’s Study Finds Memory “Replay” Persists but Loses Structure

Tau Neutralizes HSV-1 in Human Neuron Cultures, Pointing to Antiviral Roots of Alzheimer’s Features

Study Finds PU.1-Low, CD28-Positive Microglia Curb Alzheimer’s Damage

Neuron-Microglia Signal Near Plaques Emerges as a Potential Alzheimer’s Target

Chronic Neuron Overactivity in Mice Triggers Parkinson’s-Like Dopamine Cell Loss

Early Smell Loss in Alzheimer’s Driven by Microglial Axon Removal

Aging Cats Exhibit Alzheimer’s-Like Pathology and Offer Natural Model for Therapies

Dietary Compounds Restore Energy and Protein Clearance in Aging Neurons

UCSF Model Maps Genetic Drivers of Tau Vulnerability and Resilience in Alzheimer’s

MLi-2 Kinase Inhibitor Fully Restores Neuronal Cilia and Promotes Recovery in a Parkinson’s Mouse Model

New Genetic Model Predicts Early-Onset Alzheimer’s Risk and Delays

Living Human Brain Tissue Provides Breakthrough Insights Into Alzheimer’s Disease